At Keystonenanowetacklehugechallenges At Thenano Levelweredeveloping Nanoscalesolutions For Better Treatment Of Cancer And For Improvements In Difficult To Solveindustrial Chemistrieswehaveboth An Internal Development Program And A Series Of Co Development Programs With Partner Companiesusing Our Uniquenanoparticles To Deliver Their Actives Aecnanojacketskeystonenano Has An Exclusivelicenseto Technology Patented By Penn Stateuniversity That Allows Thecreation Of Stablenon Toxiclong Lasting 5 To 50 Nm Compositeparticles That Wecall Nanojacketscomposed Principally Of Calcium Phosphosilicatesthesenanojackets Can Encapsulatedrugs Or Fluorescent Moleculesunlikemost Other Nanoparticlesnanojackets Havebiocompatiblebasematerialsdissolveupon Entering Cellsand Can Bepassively Or Actively Targeted Aecnanoliposomesour Technology Allows Thecreation Of Small Liposomes With Well Defined Sizechargeand Stability That Havedemonstrated Effectiveness Against Melanomabreast Cancerand Leukemiananoliposomes Can Carry Ceramideand Other Compounds Of Interestwecan Scaleup Liposomes And Conduct A Rangeof Physical And Biological Characterizations Weinviteyou To Partner With Us To Acceleratethecommercialization Of New Products That Usenanotechnology To Improvethetreatment Of Diseaseand Thequality Of Life
